Back
Esperion Therapeutics Vs. Nektar Therapeutics Industry Stock Comparison
Buy
54
ESPR
Esperion Therapeutics
Last Price:
2.48
Seasonality Move:
33.73%
Sell
33
NKTR
Nektar Therapeutics
Last Price:
1.02
Seasonality Move:
15.74%
Buy
54
Esperion Therapeutics (ESPR)
is a Buy
Is Esperion Therapeutics a Buy, Sell or Hold?
- The current Esperion Therapeutics [ESPR] share price is $2.47. The Score for ESPR is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
- ESPR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
33
Nektar Therapeutics (NKTR)
is a Sell
Is Nektar Therapeutics a Buy, Sell or Hold?
- The current Nektar Therapeutics [NKTR] share price is $1.01. The Score for NKTR is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
- NKTR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ESPR Stock Price Chart
What is Esperion Therapeutics's stock price today?
-
The Esperion Therapeutics share price today is $2.47
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ESPR is experiencing buying pressure, which is a positive indicator for future bullish movement.
NKTR Stock Price Chart
What is Nektar Therapeutics's stock price today?
-
The Nektar Therapeutics share price today is $1.01
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NKTR is experiencing slight buying pressure.
ESPR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.1 | Buy |
| Relative Strength Index (14 RSI): | 62.51 | Buy |
| Chaikin Money Flow: | 1551144 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.03 - 2.33) | Buy |
| Bollinger Bands (100): | (1.77 - 2.33) | Buy |
NKTR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.07 | Sell |
| Relative Strength Index (14 RSI): | 30.88 | Sell |
| Chaikin Money Flow: | 16759 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.13 - 1.41) | Sell |
| Bollinger Bands (100): | (1.18 - 1.38) | Sell |
ESPR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.29 | Buy |
| 20-day SMA: | 2.2 | Buy |
| 50-day SMA: | 2.01 | Buy |
| 200-day SMA: | 2.22 | Buy |
| 8-day EMA: | 2.32 | Buy |
| 20-day EMA: | 2.22 | Buy |
| 50-day EMA: | 2.1 | Buy |
| 200-day EMA: | 2.14 | Buy |
NKTR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.11 | Sell |
| 20-day SMA: | 1.24 | Sell |
| 50-day SMA: | 1.27 | Sell |
| 200-day SMA: | 1.23 | Sell |
| 8-day EMA: | 1.1 | Sell |
| 20-day EMA: | 1.2 | Sell |
| 50-day EMA: | 1.25 | Sell |
| 200-day EMA: | 1.22 | Sell |
Esperion Therapeutics Earnings Growth & ESPR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.75 per share, and an increase next year of $0.61 per share.
Nektar Therapeutics Earnings Growth & NKTR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.58 per share, and a decrease next year of $0.08 per share.
Esperion Therapeutics Technical Analysis
| Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Nektar Therapeutics Technical Analysis
| Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||